Short Decsription
Creative Biolabs offers CHO-K1-Tg(Human W83A Receptor GPBA) Stable Cell Line which GPBA Mutant W83A receptor stably expressed in CHO-K1 cells.
Description
CHO-K1-Tg(Human W83A Receptor GPBA) Stable Cell Line was engineered to express the receptor human GPBA receptor mutant W83A (NM_170699). The GPBA receptor is activated by bile acids and is involved in various physiological processes, including metabolic regulation, energy homeostasis, and immune responses. The W83A mutation refers to the substitution of tryptophan (W) at position 83 with alanine (A). This cell line can be used to study receptor pharmacology, signaling pathways, and potential therapeutic interventions.
Features
Minimally modified GPCRs directly selected in functional assays;
Strict quality control;
Parental and orthologous cell lines are available.
Applications
Receptor pharmacology, signaling pathways, and potential therapeutic interventions.
Protein Target
GPCR
Receptor Name
GPBA mutant W83A
Receptor Family
Bile Acid
Species
Human
Parental Cell Line
CHO-K1
Transfection
Expression vector containing full-length human GPBAR1 cDNA with W83A mutation with FLAG tag sequence at N-terminus
Gene
NM_170699
Background
The GPBA (TGR5) receptor is essential for various physiological processes, including metabolic regulation and immune responses. The W83A mutation, which involves the substitution of tryptophan with alanine at position 83, can significantly impact the receptor's structure, ligand binding, and signaling functions. Research into this mutation can provide insights into its physiological and pathological consequences, potentially guiding therapeutic strategies for related disorders.

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2024 Creative Biolabs. All Rights Reserved.